VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BLXBladex, Inc.
$49.88$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBLXBalance Sheet

Bladex, Inc. (BLX) Balance Sheet

30Y historyFree accessUpdated daily

Total assets expanded from $10.9B in 2024Q2 to $16.5B in 2026Q3 against equity of only $1.8B, an equity-to-assets ratio near 0.11, which suggests a leveraged expansion funded largely by wholesale liabilities of $14.7B.

Income StatementBalance SheetCash FlowRatios

BLX Balance Sheet

Annual statement

BLX Balance Sheet

Bladex, Inc. (BLX) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash & Short Term Investments10.08B1.93B2.06B2.06B1.24B1.25B863.81M1.18B1.75B672.05M1.07B1.3B1.12B1.17B890.05M843.48M436.71M424.56M900.59M477.58M332.17M229.89M154.79M254.81M479.26M558.67M313.56M387.57M336.3M308.7M304.4M
Cash & Due from Banks1.84B1.92B1.96B2.05B1.24B1.25B863.81M1.18B1.75B672.05M1.07B1.3B780.51M839.72M707.03M843M436.71M424.56M900.59M477.58M332.17M229.89M154.79M254.81M479.26M558.67M313.56M387.57M336.3M308.7M304.4M
Short Term Investments1.85B1.57M99.49M11.87M00000000338.97M334.37M183.02M697K000000000000000
Total Investments14.17B10.64B1.3B8.29B7.78B6.53B5.3B88.79M5.79B5.53B6.02B6.9B7.06B6.52B5.98B583.7M4.54B704.84M3.35B520.96M601.43M208.57M2.52B209.81M297.74M653.97M395.46M178.82M163.9M199.2M25.8M
Investments Growth %793.14%717.73%-84.3%6.54%19.13%23.37%5863.4%-98.47%4.69%-8.24%-12.73%-2.27%8.29%9.11%924.28%-87.14%543.72%-78.99%543.84%-13.38%188.36%-91.73%1101.62%-29.53%-54.47%65.37%121.15%9.1%-17.72%672.09%3585.71%
Long-Term Investments45.8B10.64B1.2B8.28B7.78B6.53B5.3B88.79M5.79B5.53B6.02B6.9B6.73B6.19B5.8B583M4.54B704.84M3.35B520.96M601.43M208.57M2.52B209.81M297.74M653.97M395.46M178.82M163.9M199.2M25.8M
Accounts Receivables094.3M122.23M115.53M71.68M24.71M28.3M41.76M54.76M36.25M49.6M51.88M52.46M42.29M39.57M39.43M31.11M25.56M46.32M62.88M55.24M30.25M15.45M10.93M15.41M74.4M102.15M103.88M87.8M89.9M77.3M
Goodwill & Intangibles9.28M10.74M3.66M2.6M2.1M1.59M1.98M1.43M1.63M5.42M2.91M427K1.02M1.89M00000000000000000
Goodwill0000000000000000000000000000000
Intangible Assets9.28M10.74M3.66M2.6M2.1M1.59M1.98M1.43M1.63M5.42M2.91M427K1.02M1.89M00000000000000000
PP&E (Net)20.89M19.67M19.68M18.99M17.71M18.29M16.43M18.75M7.04M8.82M12.75M11.13M7.8M8.43M12.81M7M13.06M7.75M7.97M10.18M11.14M3.25M3.51M4.12M5.09M5.48M4.5M4.91M4.8M4.6M4.9M
Other Assets115.22M190.18M8.44B265.75M167.13M204.2M80.2M-108.97M12.7M17M21.32M18.98M110.78M-2.47M8.1M370K82.05M-712.59M53.69M-531.13M-612.56M-211.82M38.02M-213.93M-302.82M-659.45M-399.96M-183.72M-168.7M-203.8M-30.7M
Total Current Assets4.01B1.93B2.19B2.18B1.31B1.28B895.13M1.22B1.8B708.3M1.12B1.35B1.18B1.22B939.81M881.65M467.82M450.12M946.91M584.75M387.4M260.14M170.23M265.74M494.68M633.07M415.71M491.45M424.1M398.6M381.7M
Total Non-Current Assets12.47B10.86B9.67B8.57B7.97B6.76B5.39B108.97M5.81B5.56B6.06B6.93B6.84B6.2B5.82B590.37M4.63B712.59M3.42B531.13M612.56M211.82M2.56B213.93M302.82M659.45M399.96M183.72M168.7M203.8M30.7M
Total Assets16.48B12.79B11.86B10.74B9.28B8.04B6.29B7.25B7.61B6.27B7.18B8.29B8.02B7.42B6.76B6.36B5.1B3.88B4.36B4.79B3.98B3.16B2.73B2.56B2.93B5.93B5.66B5.17B5.59B5.75B5.31B
Asset Growth %64.44%7.82%10.38%15.72%15.5%27.81%-13.25%-4.72%21.4%-12.72%-13.34%3.29%8.15%9.79%6.23%24.7%31.49%-11.09%-8.93%20.42%25.93%15.6%6.61%-12.48%-50.56%4.68%9.45%-7.44%-2.76%8.27%16.66%
Return on Assets (ROA)1.69%1.84%1.82%1.66%1.06%0.88%0.94%1.16%0.16%1.22%1.13%1.28%1.33%1.2%1.42%1.45%0.94%1.33%1.2%1.65%1.62%2.72%5.35%4.06%-6.07%0.04%1.79%1.88%1.27%1.47%1.66%
Accounts Payable08.75M92.92M97.24M69.82M14.86M17.46M18.3M26.37M25.12M27.78M28.81M19.11M16.26M23.99M17.21M10.08M11.29M32.96M39.2M28.42M14.74M6.48M5.43M11.87M39.89M60.47M48.51M46.9M65.1M39.7M
Total Debt6.24B4.18B4.58B4.68B4.73B3.75B2B3.14B3.56B2.21B3.25B4.43B4.39B4.14B3.51B2.81B2.44B1.72B2.42B2.23B1.72B1.29B1.11B1.17B1.93B3.61B3.09B2.73B3.15B3.39B3.09B
Net Debt4.4B2.26B2.62B2.63B3.49B2.5B1.13B1.96B1.81B1.54B2.18B3.13B3.61B3.3B2.81B1.97B2B1.29B1.52B1.75B1.38B1.06B953.55M917.92M1.45B3.05B2.78B2.35B2.82B3.08B2.78B
Long-Term Debt5.97B4.03B2.7B2.63B2.22B1.72B1.59B1.52B1.5B1.14B1.78B1.88B1.4B1.15B1.91B1.49B1.08B1.39B1.2B1.01B558.86M533.86M403.62M485.52M1.29B1.79B1.58B1.21B1.27B1.42B1.21B
Short-Term Debt248.51M130.51M1.87B2.03B2.49B2.01B391.6M1.6B2.06B1.07B1.47B2.54B2.99B2.99B1.61B1.32B1.36B327.8M1.21B1.22B1.16B760.7M704.72M687.21M647.34M1.82B1.51B1.52B1.88B1.96B1.88B
Other Liabilities138.61M6.93B392.23M312.27M198.17M236.56M89.67M-1.54B51.59M51.38M87.83M53.98M182.01M32.05M23.09M-1.49B113.67M-1.39B149.63M-1.01B-558.86M-533.86M89.97M-485.52M-1.29B-1.79B-1.58B-1.21B-1.27B-1.42B-1.21B
Total Current Liabilities8.56B130.51M7.4B6.58B5.78B5.07B3.56B1.61B5.07B4.03B4.3B5.38B5.53B5.38B4B1.34B3.2B339.09M2.43B1.26B1.19B775.43M1.58B692.65M659.22M3.52B3.36B3.26B3.69B3.75B1.92B
Total Non-Current Liabilities6.13B10.98B3.12B2.96B2.44B1.98B1.69B3.14B1.55B1.19B1.86B1.94B1.58B1.18B1.93B1.49B1.19B1.39B1.35B1.01B558.86M533.86M493.6M485.52M1.29B1.79B1.58B1.21B1.27B1.42B1.21B
Total Liabilities14.69B11.11B10.52B9.54B8.21B7.05B5.25B6.23B6.62B5.22B6.17B7.31B7.11B6.56B5.93B5.59B4.38B3.2B3.78B4.18B3.39B2.54B2.07B1.98B2.59B5.31B4.95B4.47B4.96B5.17B4.79B
Total Equity1.79B1.68B1.34B1.2B1.07B991.79M1.04B1.02B993.59M1.04B1.01B971.93M911.04M859M826.48M765M716M675.64M579.01M612.25M583.89M621.93M663.99M584.33M341.4M613.65M715.02M697.32M623.7M575.5M516.3M
Equity Growth %83.03%25.54%11.08%12.58%7.82%-4.44%2.14%2.27%-4.72%3.11%4.05%6.68%6.06%3.94%8.04%6.84%5.97%16.69%-5.43%4.86%-6.12%-6.33%13.63%71.16%-44.37%-14.18%2.54%11.8%8.38%11.47%15.56%
Equity / Assets (Capital Ratio)10.86%13.13%11.28%11.2%11.52%12.34%16.5%14.02%13.06%16.64%14.08%11.73%11.36%11.58%12.23%12.03%14.04%17.42%13.27%12.78%14.68%19.69%24.3%22.79%11.65%10.36%12.63%13.48%11.16%10.02%9.73%
Return on Equity (ROE)13.96%15.05%16.2%14.62%8.93%6.18%6.19%8.56%1.09%7.98%8.78%11.04%11.57%10.06%11.69%11.23%6.07%8.75%9.25%12.07%9.6%12.46%22.71%24.09%-56.3%0.38%13.74%15.3%11.97%14.86%16.95%
Book Value per Share47.6245.2136.4033.0029.4625.5626.1725.6825.1326.5225.7924.8523.4622.2921.7820.5919.4518.4715.9016.8115.5315.9916.8720.3319.7633.4535.4433.5829.6227.8224.99
Tangible BV per Share47.3744.9236.3032.9329.4025.5226.1225.6425.0926.3825.7224.8423.4322.2421.7820.5919.4518.4715.9016.8115.5315.9916.8720.3319.7633.4535.4433.5829.6227.8224.99
Common Stock279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M279.98M000000279.98M279.98M279.98M133.23M133.22M132.85M132.85M134.8M00
Additional Paid-in Capital125.5M125.15M124.97M122.05M120.5M120.04M120.41M120.36M119.99M119.94M120.59M120.18M119.64M120.62M121.42M130.18M413.8M414.8M415.56M135.14M134.94M134.34M133.78M133.82M145.49M145.46M142.19M144.36M144M00
Retained Earnings987.03M1.08B792M673.28M543.61M487.88M464.09M446.08M423.05M479.71M587.51M560.64M501.67M454.9M422.05M373M320.15M396.6M363.64M245.35M205.2M212.92M233.7M151.02M40.74M100.67M123.84M98.01M71.1M81.1M81.7M
Accumulated OCI13.59M295.69M245.85M238.69M239.35M219.68M231.44M229.41M231.65M226.43M92.41M84.53M87.37M85.51M94.48M-3M-6.44M-6.16M-72.11M85.57M98.54M95.83M101.29M105.09M95.09M304.7M305.21M305.21M256.5M00
Treasury Stock-91.03M-97.6M-105.6M-110.17M-114.1M-115.8M-58M-59.67M-61.08M-63.25M-69.18M-73.4M-77.63M-82.01M-91.45M-115.62M-125.67M-129.6M-132.76M-133.79M-134.77M-106.28M-92.63M-85.57M-85.63M-85.63M-4.89M0000
Preferred Stock0000000000000000000005.15M7.86M012.48M15.23M15.81M16.89M17.2M17.2M17.2M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile non-interest income and credit provisions

Asset Base Expands Faster Than Equity

As reported in the balance sheet data, Bladex's total assets grew from $10.9B in 2024Q2 to $16.5B in 2026Q3, while equity rose only from $1.3B to $1.8B, suggesting a leveraged expansion that warrants closer scrutiny of asset quality.

Total assets rose roughly 51% over the ten quarters while equity grew about 38%, pushing the equity-to-assets ratio down from roughly 0.12 to 0.11. Investment securities expanded from about $8.6B to $14.2B, which appears to indicate that a meaningful share of the growth came from securities rather than the trade finance loan book that defines the franchise. Investors should monitor whether this mix shift reflects a deliberate liquidity posture or a drift away from core lending.

Funding Base Relies on Wholesale Sources

Based on Bladex's reported figures, total liabilities of $14.7B in 2026Q3 against cash and bank balances of $1.8B indicate a funding structure that depends heavily on wholesale and interbank borrowings rather than a granular deposit base.

Because the supplied data does not break out deposit composition, the deposit beta and non-interest-bearing share cannot be assessed and are treated here as data unavailable. The liability growth in line with asset growth is consistent with a wholesale-funded model typical of supranational-style trade lenders. The quality of this funding franchise therefore depends on continued access to international capital markets, which warrants further investigation.

Provision Spike Breaks Subdued Credit Pattern

As reported in financial statements, Bladex's loan loss provisions jumped from roughly $5M per quarter through 2025 to $107M in 2026Q2 and $111M in 2026Q1, a shift that appears material against quarterly net income near $55M.

The move from low single-digit provisions to over $100M per quarter suggests a sharp revision in expected credit loss assumptions rather than a gradual deterioration, though the supplied data does not disclose nonperforming loans or charge-off detail to confirm the cause. The sign convention in the provision line is inconsistent across quarters, so the exact direction of the reserve movement should be verified against the filings. Investors should treat the 2026 credit cost figures as a key item requiring further verification.

Equity Cushion Thin Relative to Assets

Based on Bladex's reported figures, equity of $1.8B against total assets of $16.5B implies an equity-to-assets ratio near 0.11, which is modest for a bank holding a large securities book and warrants monitoring of regulatory capital ratios.

The supplied data does not include CET1, Tier 1, or leverage ratios, so regulatory capital adequacy is treated as data unavailable and no conclusion about compliance is drawn. The declining equity-to-assets ratio over the period suggests capital has not kept pace with balance sheet growth. Investors should look for disclosed capital ratios before assessing buffer capacity for dividends or expansion.

Liquid Assets Rise With Securities Growth

As reported in financial statements, Bladex's cash and bank balances stayed near $1.8B to $2.0B across the period while investment securities expanded to $14.2B, suggesting a liquidity profile increasingly anchored in the securities portfolio.

Cash and bank balances held roughly flat while securities grew substantially, which appears to indicate a larger reliance on the securities book as a source of liquidity. The data does not disclose the liquid share of that portfolio or the maturity profile, so the true liquidity buffer cannot be confirmed. Investors should monitor the composition and marketability of the securities holdings.

Equity Growth Masks Earnings Quality Questions

Based on Bladex's reported figures, reported return on equity has stayed in a narrow 3.3% to 4.6% band, but the volatility in non-interest income and provisions raises questions about whether these returns reflect durable earnings power.

Quarterly net income held near $50M to $66M, yet the swings in non-interest income and credit costs suggest that headline profitability may be less stable than the ROE figures imply. A low ROE combined with a thin equity base and rising assets could indicate that incremental balance sheet growth is not generating proportionate returns. This pattern warrants further investigation before treating the current capital base as a strength.

BLX — Frequently Asked Questions

Quick answers to the most common questions about buying BLX stock.

What are the total assets of Bladex, Inc. (BLX)?

As of 2025, Bladex, Inc. (BLX) had total assets of $12.79B including $1.93B in current assets.

How much debt does Bladex, Inc. (BLX) have?

Bladex, Inc. (BLX) carries total debt of $4.18B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Bladex, Inc.?

Bladex, Inc. (BLX) has total shareholders' equity (book value) of $1.68B ($45.21 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Bladex, Inc.'s current ratio and liquidity?

Bladex, Inc. (BLX) reported a current ratio of 14.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.